Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Ruth L. Coleman"'
Autor:
Liam Mc Morrow, Frauke Becker, Ruth L. Coleman, Hertzel C. Gerstein, Lars Rydén, Stefan Schöder, Alastair M. Gray, Jose Leal, Rury R. Holman, for the ACE Study Group
Publikováno v:
Journal of Diabetes, Vol 16, Iss 2, Pp n/a-n/a (2024)
Abstract Background The Acarbose Cardiovascular Evaluation (ACE) trial (ISRCTN91899513) evaluated the alpha‐glucosidase inhibitor acarbose, compared with placebo, in 6522 patients with coronary heart disease and impaired glucose tolerance in China
Externí odkaz:
https://doaj.org/article/3a39a6e3ce5e49cc929e23525a5b76a3
Autor:
Nantia Othonos, Riccardo Pofi, Anastasia Arvaniti, Sarah White, Ilaria Bonaventura, Nikolaos Nikolaou, Ahmad Moolla, Thomas Marjot, Roland H. Stimson, André P. van Beek, Martijn van Faassen, Andrea M. Isidori, Elizabeth Bateman, Ross Sadler, Fredrik Karpe, Paul M. Stewart, Craig Webster, Joanne Duffy, Richard Eastell, Fatma Gossiel, Thomas Cornfield, Leanne Hodson, K. Jane Escott, Andrew Whittaker, Ufuk Kirik, Ruth L. Coleman, Charles A. B. Scott, Joanne E. Milton, Olorunsola Agbaje, Rury R. Holman, Jeremy W. Tomlinson
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-12 (2023)
Glucocorticoids prescribed to limit inflammation, have significant adverse effects. Here the authors show that co-administration of AZD4017 with prednisolone in men is a potential strategy to limit adverse glucocorticoid effects.
Externí odkaz:
https://doaj.org/article/d5729cc721e9453cb5043aab11c131a3
Autor:
Shishi Xu, Ruth L. Coleman, Qin Wan, Yeqing Gu, Ge Meng, Kun Song, Zumin Shi, Qian Xie, Jaakko Tuomilehto, Rury R. Holman, Kaijun Niu, Nanwei Tong
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-12 (2022)
Abstract Background People with intermediate hyperglycemia (IH), including impaired fasting glucose and/or impaired glucose tolerance, are at higher risk of developing type 2 diabetes (T2D) than those with normoglycemia. We aimed to evaluate the perf
Externí odkaz:
https://doaj.org/article/6ed5f2be67704fe7b5cca1980bbe1294
Autor:
Ruth L. Coleman, Charles A. B. Scott, Zhihui Lang, M. Angelyn Bethel, Jaakko Tuomilehto, Rury R. Holman
Publikováno v:
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-7 (2019)
Abstract Background Alpha-glucosidase inhibitors (AGIs) have been shown to reduce incident type 2 diabetes but their impact on cardiovascular (CV) disease remains controversial. We sought to identify the overall impact of AGIs with respect to inciden
Externí odkaz:
https://doaj.org/article/4b92b34490fa4cb3b672ed86acd45a80
Publikováno v:
Preventive Medicine Reports, Vol 8, Iss , Pp 51-54 (2017)
Health selection into neighborhoods may contribute to geographic health disparities. We demonstrate the potential for clinical trial data to help clarify the causal role of health on locational attainment. We used data from the 20-year United Kingdom
Externí odkaz:
https://doaj.org/article/0e83c8f04c404bfda22e9a45c1b441a4
Autor:
Abderrahim Oulhaj, Faisal Aziz, Abubaker Suliman, Nayyar Iqbal, Ruth L. Coleman, Rury R. Holman, Harald Sourij
Publikováno v:
Diabetes, Obesity and Metabolism. 25:1261-1270
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::692171662b02b9f0013b748bf1997aad
https://doi.org/10.1111/dom.14975
https://doi.org/10.1111/dom.14975
Autor:
null Abderrahim Oulhaj, null Faisal Aziz, null Abubaker Suliman, null Nayyar Iqbal, null Ruth L. Coleman, null Rury R. Holman, null Harald Sourij
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cabb15da02193e8f8386480e1d5917f0
https://doi.org/10.1111/dom.14975/v2/response1
https://doi.org/10.1111/dom.14975/v2/response1
Autor:
Stephen P Juraschek, Jiun-Ruey Hu, Jennifer L Cluett, Anthony M Ishak, Carol Mita, Lewis A Lipsitz, Lawrence J Appel, Nigel S Beckett, Ruth L Coleman, William C Cushman, Barry R Davis, Greg Grandits, Rury R Holman, Edgar R Miller, Ruth Peters, Jan A Staessen, Addison A Taylor, Jackson T Wright, Kenneth J Mukamal
Publikováno v:
Hypertension. 79
Background: In a recent individual level meta-analysis, intensive versus standard blood pressure (BP) treatment reduced participants’ risk of orthostatic hypotension (OH). Whether OH modified the relationship between intensive treatment and risk of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6547204c70a944398df03b5ec555aa6b
https://doi.org/10.1161/hyp.79.suppl_1.p220
https://doi.org/10.1161/hyp.79.suppl_1.p220
Autor:
Eleanor Wicks, Hanan Lamlum, Jyothis T. George, Olorunsola F. Agbaje, Christopher T. Rodgers, Rury R. Holman, Oliver J Rider, Ladislav Valkovič, Heiko G. Niessen, Rolf Grempler, Stefan Neubauer, Moritz Hundertmark, Joanne E. Milton, Jisoo Lee, Ruth L. Coleman, Masliza Mahmod
Publikováno v:
ESC Heart Failure, Vol 8, Iss 4, Pp 2580-2590 (2021)
ESC Heart Failure
ESC Heart Failure
Aims Despite substantial improvements over the last three decades, heart failure (HF) remains associated with a poor prognosis. The sodium-glucose co-transporter-2 inhibitor empagliflozin demonstrated significant reductions of HF hospitalization in p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c963ade06b856a2fa857cae15b1d938c
https://doaj.org/article/70e5e797e27347219ca852428a66c514
https://doaj.org/article/70e5e797e27347219ca852428a66c514
Publikováno v:
Diabetes Care
OBJECTIVE Type 2 diabetes all-cause mortality (ACM) and myocardial infarction (MI) glycemic legacy effects have not been explained. We examined their relationships with prior individual HbA1c values and explored the potential impact of instituting ea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54d58ac42d78981b46b7dc2c582446db
https://doi.org/10.2337/dc20-2439
https://doi.org/10.2337/dc20-2439